Suvanza Pharma Llc Stock Net Income
| SUVZ Stock | USD 0.0002 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Suvanza Pharma's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -15.2 M | -15.9 M | |
| Net Loss | -15.2 M | -15.9 M | |
| Net Loss | -15.2 M | -15.9 M |
Suvanza | Net Income | Build AI portfolio with Suvanza Stock |
Suvanza Pharma LLC Company Net Income Analysis
Suvanza Pharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Suvanza Pharma Net Income | (16.84 M) |
Most of Suvanza Pharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Suvanza Pharma LLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Suvanza Operating Income
Based on the recorded statements, Suvanza Pharma LLC reported net income of (16.84 Million). This is 104.93% lower than that of the Biotechnology sector and 124.03% lower than that of the Health Care industry. The net income for all United States stocks is 102.95% higher than that of the company.
Suvanza Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Suvanza Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Suvanza Pharma could also be used in its relative valuation, which is a method of valuing Suvanza Pharma by comparing valuation metrics of similar companies.Suvanza Pharma is currently under evaluation in net income category among its peers.
Suvanza Fundamentals
| Current Valuation | 1.34 M | ||||
| Price To Book | 0.35 X | ||||
| Net Income | (16.84 M) | ||||
| Total Debt | 24 K | ||||
| Cash Flow From Operations | (12.4 M) | ||||
| Beta | -13.19 | ||||
| Market Capitalization | 1.01 M | ||||
| Total Asset | 8.73 M | ||||
| Retained Earnings | (67.16 M) | ||||
| Working Capital | (226 K) | ||||
| Current Asset | 1.75 M | ||||
| Current Liabilities | 1.97 M | ||||
| Net Asset | 8.73 M |
About Suvanza Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Suvanza Pharma LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Suvanza Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Suvanza Pharma LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Suvanza Stock Analysis
When running Suvanza Pharma's price analysis, check to measure Suvanza Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Suvanza Pharma is operating at the current time. Most of Suvanza Pharma's value examination focuses on studying past and present price action to predict the probability of Suvanza Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Suvanza Pharma's price. Additionally, you may evaluate how the addition of Suvanza Pharma to your portfolios can decrease your overall portfolio volatility.